February 28, 2019
Pharmaceutical leader Cam Garner and his wife Wanda, a cancer workshop facilitator and philanthropic fundraiser, recently gave $2 million to establish the Garner Family Chancellor’s Endowed Chair in Blood and Marrow Transplant at UC San Diego Moores Cancer Center.
October 8, 2015
…the Department of Pediatrics, Hematology/Oncology. Batova and Lou Bridgeman, a former staff research associate in Dr. Yu’s lab, were key contributors to the pre-clinical research that helped develop Unituxin. Unituxin works by inducing the body’s immune system to recognize cancerous nerve cells as antigens and attack them. More precisely, the…
March 30, 2015
Working closely with other campus entities to translate ideas from the lab into products and companies in the marketplace, the Qualcomm Institute has launched an Innovation Space where qualified faculty startups, industry partners or national laboratories can lease office or lab space inside the research institute’s headquarters building on the…
May 23, 2023
UC San Diego’s Class of 2023 are diverse, perseverant and passionate about making a difference. They have reached for the stars and left the UC San Diego community better than they found it. Read more about some of our stunning graduates here.
October 31, 2023
UC San Diego Health provides the highest standards of care by multi-disciplinary teams from expectant parents to patients going through menopause.
November 6, 2014
…Division Chief, Division of Hematology-Oncology, Senior Deputy Center Director for Clinical Science Personalized Cancer Therapy: Promise and Challenge What initially sparked your curiosity about this area of study? My interest was sparked by the deep science underlying genomics and the breathtaking advances in the tools available to interrogate tumor molecular…
November 14, 2011
…Assistant Professor of Medicine, Hematologic Malignancies Program Dr. Jamieson is researching cancer stem cells derived from human embryonic stem cells. Compelling studies suggest that human cancer stem cells (CSC) arise from aberrantly self-renewing, tissue-specific stem or progenitor cells which are responsible for cancer propagation and therapeutic resistance. Human embryonic stem…
June 6, 2016
In a meta-analysis of hundreds of clinical trials involving thousands of patients, researchers at University of California San Diego School of Medicine report that therapeutic approaches using precision medicine, which emphasizes the use of individual genetics to refine cancer treatment, showed improved response and longer periods of disease remission, even…
September 20, 2016
…researchers to hold meeting in San Diego to discuss hematologic malignancies as part of the University of California Hematologic Malignancies Consortium, a first-of-its-kind research group that brings together the five UC health campuses conducting clinical studies for cancer patients. The consortium currently has four additional clinical trials planned for 2017.
June 11, 2020
Using induced pluripotent stem cells (iPSCs) and deleting a key gene, researchers at University of California San Diego School of Medicine have created natural killer cells — a type of immune cell — with measurably stronger activity against a form of leukemia, both in vivo and in vitro.
